COMPLICATED URINARY TRACT INFECTION
Clinical trials for COMPLICATED URINARY TRACT INFECTION explained in plain language.
Never miss a new study
Get alerted when new COMPLICATED URINARY TRACT INFECTION trials appear
Sign up with your email to follow new studies for COMPLICATED URINARY TRACT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapons against superbugs: trial tests promising antibiotic combos
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for serious, drug-resistant bacterial infections. It involved 126 hospitalized adults with infections like pneumonia, urinary tract infections, o…
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New antibiotic duos battle Drug-Resistant kidney infections
Disease control CompletedThis large, completed Phase 3 study tested whether two new combinations of antibiotics (cefepime/nacubactam and aztreonam/nacubactam) work as well as a standard antibiotic (imipenem/cilastatin) for treating serious urinary tract or kidney infections in adults. The main goal was t…
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New antibiotic combo battles tough kidney infections in hospital trial
Disease control CompletedThis study tested whether a new antibiotic combination (cefepime-zidebactam) works as well as a standard antibiotic (meropenem) for treating serious urinary tract or kidney infections that require hospitalization. About 530 adults with these infections received one of the two tre…
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC